News Archives - Page 2 of 803

TuesdayAug 04, 2026 9:00 am

Azio AI Holdings Inc. (NASDAQ: AZIO) Is ‘One to Watch’

AZIO AI is building an integrated technology infrastructure platform focused on AI data centers, enterprise GPU compute, high-performance computing and digital power solutions. In July 2026, the company completed its merger with AZIO AI Corporation and subsequently changed its corporate name and Nasdaq ticker symbol from EVTV to AZIO, completing its transformation into a dedicated AI infrastructure company. AZIO AI has announced a $27.9 million AI infrastructure and capacity agreement with Power Champion Investment Limited that is scalable to as much as $100 million as deployment expands. The company has reported receiving initial deposits under the agreement. The company recently…

MondayAug 03, 2026 9:00 am

Safe Pro Group Inc. (NASDAQ: SPAI) Projects Major Year-Over-Year Q2 2026 Revenue Growth

Safe Pro Group has announced that it expects revenue in Q2 2026 to increase over 1,300% year-over-year, to more than 1.3 million. This large growth is driven by multiple U.S. Army subcontract awards for Safe Pro’s AI-powered threat detection and mapping software packages. Safe Pro has also expanded its AI offering from just the air, to the ground, supporting both drones and autonomous unmanned ground vehicles (“UGVs”). Safe Pro Group (NASDAQ: SPAI), a tech company that delivers AI-powered security and defense solutions, recently announced that it expects year-over-year revenue to climb dramatically in Q2 2026, based on preliminary and unaudited…

FridayJul 31, 2026 2:45 pm

Beeline Holdings Inc. (NASDAQ: BLNE) to Update Investors on Q2 Results as Digital Mortgage Strategy Targets Changing Housing Market

The company will host a stakeholder update call on August 13, 2026, to discuss second-quarter financial results and business initiatives. Beeline is using artificial intelligence and automation to shorten mortgage approval and closing timelines while serving both homebuyers and real estate investors. Beeline is addressing financing challenges facing Millennials and Generation Z through digital underwriting designed to provide rapid qualification assessments. The company is also expanding products aimed at older homeowners seeking to access home equity without refinancing existing low-rate mortgages. Q1 2026 results showed revenue and loan originations more than doubling from the prior-year period despite a challenging mortgage…

FridayJul 31, 2026 2:00 pm

Market Street Capital Inc. Positions Middle-Market Founders to Capitalize on Expanding Private Credit Options

We believe that the decision between debt and equity is one of the most consequential a business owner will ever make, and it is rarely as simple as comparing interest rates to dilution percentages. The challenge is that middle-market businesses do not always have clean access to traditional bank financing. That diagnostic work is precisely where Market Street Capital's capital markets practice seeks to add value. When a founder needs capital to grow, two doors open simultaneously; choosing the wrong one can reshape the company's future in ways that take years to fully understand. A boutique capital markets and financial advisory firm,…

ThursdayJul 30, 2026 9:45 am

SS Innovations International Inc. (NASDAQ: SSII) Expands Global Footprint on Fast-Growing Robotic Surgery Market

The company is expanding its presence in the global surgical robotics market through its proprietary SSi Mantra robotic surgery platform. The company's strategy combines world-class robotic systems, including telesurgery capabilities, with affordability, physician training, and international market expansion. More than 200 SSi Mantra systems have been installed worldwide, supporting over 12,000 robotic procedures across more than 170 surgical indications. SS Innovations continues pursuing U.S. FDA clearance and European regulatory approvals while building its installed base internationally. Growing demand for minimally invasive surgery and broader access to robotic procedures continues to create opportunities for emerging high-tech medical technology companies. The market…

ThursdayJul 30, 2026 9:00 am

Market Street Capital Inc. Guides Founders to Know When — and How — to Walk Away on Their Own Terms

Exit readiness is one of the most important and most overlooked strategic disciplines for founders of privately held businesses. One of the most common mistakes founders make is waiting until they are emotionally ready to sell before beginning any preparation. Market Street Capital’s advisory practice helps founders organize their records, align their team and prepare their narrative. Most business owners spend years building something worth selling, then spend far too little time thinking about how to actually sell it. That gap between building a valuable company and knowing when and how to exit is where significant value is won or…

WednesdayJul 29, 2026 10:30 am

Wrap Technologies Inc. (NASDAQ: WRAP) Builds Global Momentum as It Expands the WrapShield(TM) Public Safety Platform

Regulatory clarity: ATF Ruling 2026-2, effective July 2, 2026, classified the BolaWrap(R) 150 as a federally recognized instrument of restraint rather than a firearm or “any other weapon” — which may remove longstanding procurement barriers across law enforcement, corrections, and government markets and is helping agencies move from extended evaluation toward department-wide programs. Counter-drone sensing: A strategic transaction with Israeli AI sensing company Frenel Imaging Ltd. gives WRAP exclusive U.S. and NATO distribution rights to Division of Focal Plane (“DoFP”) polarimetric sensing technology, which detects drones by their physical light-scattering signatures rather than radio-frequency emissions — enabling detection, the company…

WednesdayJul 29, 2026 9:45 am

VERAXA Biotech AG (NASDAQ: VRXA) Strengthens Scientific Leadership as New CSO Takes the Helm in Advancing BiTAC(R) Cancer Therapy Platform

The company has appointed antibody therapeutics specialist Dr. Christoph Erkel as Chief Scientific Officer. The leadership change comes as the company advances its proprietary BiTAC(R) technology platform toward clinical development. VERAXA is building a diversified oncology pipeline that includes conditionally active T-cell engagers, bispecific ADCs and other engineered antibody therapeutics. Recent regulatory feedback from Germany's Paul-Ehrlich-Institute has provided additional clarity for development of the company's lead BiTAC(R)-TCE program. Investors are watching companies developing next-generation immunotherapies that seek to improve efficacy while reducing treatment-related toxicity. VERAXA Biotech (NASDAQ: VRXA), an emerging leader in designing novel cancer therapies, has appointed antibody therapeutics…

WednesdayJul 29, 2026 9:20 am

QualityStocksNewsBreaks – Streamex Corp. (NASDAQ: STEX) Highlights Tokenization Platform Strategy in Investor Video

Streamex (NASDAQ: STEX) released an investor video featuring Vice President of Product and Design Kori Handy, outlining the company's long-term strategy to build a tokenized commodity infrastructure extending well beyond gold. The presentation emphasizes that while GLDY serves as the company's initial asset, the underlying custody, compliance, liquidity, banking and distribution infrastructure is designed to support future tokenized commodities including silver, oil and gas, and copper. Streamex also highlighted partnerships with Siebert Financial, Inspira Financial, Equity Trust, tZERO, Wintermute, Coinbase Prime, Anchorage Digital and BitGo as components of its expanding distribution and trading ecosystem. The company said its roadmap includes…

WednesdayJul 29, 2026 9:00 am

QualityStocksNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Expands Patent Portfolio to Support Next-Generation Cancer Therapy Platforms

VERAXA Biotech (NASDAQ: VRXA) announced an expansion of its intellectual property portfolio, filing new patent applications during the first half of 2026 covering its next-generation BiTAC-TCE and BiTAC-ADC technology platforms and related therapeutic programs. The company said previously granted patents protecting supporting technologies have also cleared the opposition period, bringing its portfolio to more than 50 granted owned or exclusively licensed patents across 14 countries and 26 patent families. Pending approval of the latest filings, VERAXA expects its core technologies to be protected through at least 2047. The company said its BiTAC platform is designed to improve the selectivity and…

Site Search

Company Search

Category: News